Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive has built a robust product pipeline that has a particular focus on infectious diseases and rare disorders and is discovering and developing new therapeutic uses of drugs such as Bucillamine, Psilocybin and Cannabidiol. We are steadily advancing our product development programs that will unlock the potential value of Revive and we are continuing to expand our product pipeline in infectious diseases and rare disorders.


Top institutional share ownership of Revive Therapeutics Ltd.

Name Shares Shares % change Value Value % change
Gofen & Glossberg Llc /il/ 130,000 18.7% $11 -42.1%
MAI Capital Management 25,000 0.0% $4 -55.6%
FineMark National Bank & Trust 10,345 $2

Top institutional buyers of Revive Therapeutics Ltd.

Name Shares % change Value % change Shares Value
Gofen & Glossberg Llc /il/ 18.7% -42.1% 130,000 $11

Top institutional sellers of Revive Therapeutics Ltd.

Name Shares % change Value % change Shares Value

Information provided by Fintel.io